Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

Medicine, Neurology, Neuroscience +10

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

Claudia F. Lucchinetti, Wolfgang Br�ck, Joseph E. Parisi et al. · Annals of Neurology · 2000 · 3.3K citations

Life Sciences, Neurology, Pathology +17

Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults

Anne Rentoumis Cappola, Linda P. Fried, Alice M. Arnold et al. · JAMA · 2006 · 866 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +16

Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis

Feng Mei, Stephen P.J. Fancy, Yun‐An Shen et al. · Nature Medicine · 2014 · 590 citations

Engineering, Neurology, Neuroscience +11

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Ari Green, Jeffrey M. Gelfand, Bruce Cree et al. · The Lancet · 2017 · 577 citations · Full text

Life Sciences, Neurology, Neuroscience +13